| 1 | 4XPA |
Sodium-dependent dopamine transporter | Drosophila melanogaster |
Q7K4Y6 (DAT_DROME) |
2-(3,4-dichlorophenyl)ethanamine |
42J |
 |
SHOW |
| 2 | 2Y80 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
6-CHLORO-N-{(3S)-1-[(1S)-1-(DIMETHYLAMINO)-2,3-DIHYDRO-1H-INDEN-5-YL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE |
439 |
 |
SHOW |
| 3 | 4CWD |
Gamma-butyrobetaine dioxygenase | Homo sapiens |
O75936 (BODG_HUMAN) |
4-carboxy-1,1-dimethylpiperidin-1-ium |
449 |
 |
SHOW |
| 4 | 4Y7B |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
6-chloro-N-{(3S)-1-[(2S)-1-{(1R,5S)-7-[2-(methylamino)ethyl]-3,7-diazabicyclo[3.3.1]non-3-yl}-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide |
44I |
 |
SHOW |
| 5 | 2XBW |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(3R,4R)-1-SULFAMOYL-PYRROLIDINE-3,4-DICARBOXYLIC ACID 3-[(4-CHLORO-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE} |
455 |
 |
SHOW |
| 6 | 4Y6D |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(3S)-3-({[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonyl}amino)-2-oxopyrrolidin-1-yl]-3-fluoro-N,N-dimethylbenzamide |
48U |
 |
SHOW |
| 7 | 4Y86 |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | Homo sapiens |
O76083 (PDE9A_HUMAN) |
6-{[(1S)-1-(4-chlorophenyl)ethyl]amino}-1-cyclopentyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one |
49D |
 |
SHOW |
| 8 | 3PPR |
Glycine betaine/carnitine/choline-binding protein OpuCC | Bacillus subtilis |
O32243 (OPUCC_BACSU) |
(4S)-2-METHYL-1,4,5,6-TETRAHYDROPYRIMIDINE-4-CARBOXYLIC ACID |
4CS |
 |
SHOW |
| 9 | 4YZU |
Coagulation factor IX | Homo sapiens |
P00740 (FA9_HUMAN) |
N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-4-(4H-1,2,4-triazol-4-yl)benzamide |
4K6 |
 |
SHOW |
| 10 | 5C6S |
Peregrin | Homo sapiens |
P55201 (BRPF1_HUMAN) |
isoquinoline-3-carboxylic acid |
4K8 |
 |
SHOW |
| 11 | 4Y76 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
N~2~-[(6-chloronaphthalen-2-yl)sulfonyl]-N~2~-{(3S)-1-[(2S)-1-(4-methyl-1,4-diazepan-1-yl)-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl}glycinamide |
4O1 |
 |
SHOW |
| 12 | 4ZHA |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(3S)-3-({[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonyl}amino)-2-oxo-2,3-dihydro-1H-pyrrol-1-yl]-3-fluoro-N-methylbenzamide |
4O5 |
 |
SHOW |
| 13 | 4ZJS |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
1-[(1R,6R)-9-azabicyclo[4.2.1]non-2-en-2-yl]ethanone |
4P0 |
 |
SHOW |
| 14 | 6SH0 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
1-[(1R,6R)-9-azabicyclo[4.2.1]non-2-en-2-yl]ethanone |
4P0 |
|
SHOW |
| 15 | 1XKA |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(2S)-(3'-AMIDINO-3-BIPHENYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID |
4PP |
 |
SHOW |
| 16 | 5FP9 |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
3-AMINOPYRIDINE-4-CARBOXYLIC ACID |
4SV |
 |
SHOW |
| 17 | 5BUH |
Polymerase basic protein 2 | Influenza A virus |
Q30NP1 (PB2_I75A0) |
N-[(1R,3S)-3-({5-fluoro-2-[5-fluoro-2-(hydroxymethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-4-yl}amino)cyclohexyl]pyrrolidine-1-carboxamide |
4V7 |
 |
SHOW |
| 18 | 5BW2 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(2R)-2-(pyridin-3-yl)-1-azabicyclo[2.2.2]octane |
4VU |
 |
SHOW |